patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Manolo..I have the utmost confidence in Pluristem. I will truly miss
Craig Bird's Segue Ventures coverage of PSTI..Craig is a class act with impeccable credentials imo! Craig Bird wishes PSTI investors the best of luck and will continue to allow posting for a few weeks by investors wishing to communicate with each other on his site. Craig Bird further states that Pluristem is a really great company..see his statement on Segue Ventures LLC re same
Share
New Message
Please login to post a reply